GSK, Spero to stop urinary tract infection drug trial due to early success-February 2024-www.financetom.com

GSK, Spero to stop urinary tract infection drug trial due to early success

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GSK, Spero to stop urinary tract infection drug trial due to early success

May 28, 2025 4:34 AM

May 28 (Reuters) - Spero Therapeutics ( SPRO ) and

partner GSK said on Wednesday that an experimental drug

for complicated urinary tract infections met the main goal of a

late-stage trial and the companies will be stopping the trial

early for efficacy.

(Reporting by Sriparna Roy in Bengaluru; Editing by Devika

Syamnath)

Previous page： Archer Aviation, Anduril Industries Collaborate to Develop Hybrid VTOL Aircraft Next page： BRIEF-SA's Competition Tribunal Approves Nikisize Ltd - Autozone Holdings Merger, With Conditions

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Archer Aviation, Anduril Industries Collaborate to Develop Hybrid VTOL Aircraft

Dec 12, 2024

09:46 AM EST, 12/12/2024 (MT Newswires) -- Archer Aviation ( ACHR ) said Thursday it is collaborating with Anduril Industries to co-develop a hybrid verticle take-off and landing aircraft for defense applications, for a potential US Department of Defense initiative. Financial details weren't disclosed. To advance this initiative Archer raised $430 million in equity funding from Stellantis ( STLA )...

BRIEF-SA's Competition Tribunal Approves Nikisize Ltd - Autozone Holdings Merger, With Conditions

Dec 12, 2024

Dec 12 (Reuters) - SA'S COMPETITION TRIBUNAL: * SA'S COMPETITION TRIBUNAL: APPROVED NIKISIZE (PTY) LTD - AUTOZONE HOLDINGS (PTY) MERGER, WITH CONDITIONS ...

Canadian Pacific Kansas City, Americold Realty Trust to Explore Project Opportunities in Mexico

Dec 12, 2024

09:46 AM EST, 12/12/2024 (MT Newswires) -- Canadian Pacific Kansas City ( CP ) (CP, CP.TO) and Americold Realty Trust ( COLD ) said Thursday that they will formally explore co-development opportunities in Mexico under their collaboration to optimize temperature-sensitive logistics between the US, Mexico and Canada. The companies formed the collaboration last year and broke ground on their planned...

Esperion Therapeutics Signs Licensing Deal for Nexletol, Nexlizet in Israel

Dec 12, 2024

09:47 AM EST, 12/12/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) said Thursday it has signed a licensing deal with Neopharm Israel for the exclusive rights to commercialize cholesterol medications Nexletol and Nexlizet in Israel. Under the terms of the agreement, Esperion will grant Neopharm exclusive commercialization rights to the drugs in Israel, Gaza, and the West Bank. In...